PHARMACEUTICALS

cognitive performances

When Should a Prescription Drug's Side Effects Count as a Disability?

“Part of me can kind of understand where they're coming from, but most of me doesn't.”
Sarah Scoles
9.11.17
When the Drugs Hit

America's Trippiest Chemist: Making Psychedelics 'Was Fun'

For over 40 years, Dave Nichols had government license to make Schedule 1 drugs like LSD and DMT for research.
Daniel Oberhaus
6.2.17
Pharma

To Solve Opioid Addiction, We Still Need to Solve Pain

We know a whole lot about painkillers, but not much about pain itself.
Michael Byrne
3.10.17
Twitter

Twitter Finally Cracked Down on ‘Pharma Bro’ Martin Shkreli

Writer Lauren Duca has reported a ton of harassment after she appeared on Fox News.
Kaleigh Rogers
1.9.17
migraines

When It Comes To Migraines, the Drugs Are Almost As Bad As the Pain

For migraine sufferers, picking the right medication can be a real headache.
Sarah Emerson
9.1.16
Features

Is Big Pharma Out to Stop—Or Take Over—Marijuana Legalization?

Pharmaceutical companies might not have to actively oppose cannabis legalization to cause problems for the marijuana movement.
Joel Warner
8.25.16
MIT

MIT Develops Portable Device That Spits Out Drugs On-Demand

The new microbioreactor could be big news for medicine in the developing world.
Michael Byrne
7.31.16
Canada

How a Canadian Pharmacist Is Planning to Overthrow the Tyranny of Doctors

Roger Simard wants to monitor every patient with smart wearables.
Mark Mann
6.22.16
Health

Narcotic Painkillers Prolong Pain in Rats

According to a new study, even a few days of opioid treatment can extend chronic pain by months.
Michael Byrne
5.30.16
Drugs

The Chemistry of Ketamine and Depression Isn't What It Seems

Ketamine seems to be a quick, effective treatment for depression, but researchers are only now figuring out why.
Michael Byrne
5.4.16
vr

Excedrin, I Don’t Want Your Migraine AR Simulator, I Just Want Better Drugs

Why does this exist?
Sarah Emerson
4.8.16
News

This Is Why the Feds Arrested Martin Shkreli

Long before he started drawing public rage for his drug price hike, Shkreli ran a couple of hedge funds.
Kaleigh Rogers and Rachel Pick
12.17.15
Newer0104Older